Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 0 | 25 | 25 | 8,749 | 408 |
| Gross Profit | N/A | 25 | 25 | 8,749 | 408 |
| Operating Expenses | 16,576 | 10,663 | 12,199 | 8,532 | 7,641 |
| Operating Income | -16,576 | -10,638 | -12,174 | 216 | -7,233 |
| Interest Expense | 25 | 42 | 32 | 14 | 34 |
| Other Income | 290 | 213 | 469 | 540 | 4,942 |
| Pre-tax Income | -16,311 | -10,467 | -11,737 | 742 | -2,324 |
| Income Tax | N/A | N/A | -102 | 200 | -177 |
| Net Income Continuous | -16,311 | -10,467 | -11,636 | 542 | -2,147 |
| Net Income | $-16,311 | $-10,467 | $-11,636 | $542 | $-2,147 |
| EPS Basic Total Ops | -32,053.56 | -26,909.16 | -34,032.18 | 1,978.62 | -9,101.63 |
| EPS Basic Continuous Ops | -32,001.56 | -26,716.51 | -33,947.49 | 2,085.44 | -9,291.01 |
| EPS Diluted Total Ops | -32,053.56 | -26,909.16 | -34,032.18 | 1,978.62 | -9,101.63 |
| EPS Diluted Continuous Ops | -32,001.56 | -26,716.51 | -33,947.49 | 1,942.01 | -9,291.01 |
| EBITDA(a) | $-16,060 | $-10,258 | $-11,594 | $472 | $-6,875 |